|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Glycemic durability of rosiglitazone,metformin,or glyburide monotherapy显示文摘 | Kahn SE Haffner SM Heise MA | | New England Journal of Medicine0，，： | 2 |
| 2 | Characteristics of group of adolescents undergoing loop electrical excision procedure(LEEP)显示文摘 | Perlman SE Lubianca JN Kahn JA | 2003 | J Pediatr Adolesc Gynecol2003，16，1： | 1 |
| 3 | Mechanisms linking obesity to insulin resistance and type 2 diabetes显示文摘 | Kahn SE Hull RL Utzschneider KM | 2006 | Nature2006，444，7121： | 1 |
| 4 | PLTP activity decreases with weight loss: changes in PLTP are associated with changes in subcutaneous fat and FFA but not IAF or insulin sensitivity 显示文摘 | Murdoch SJ Kahn SE Albers JJ | 2003 | J Lipid Res2003，44，9： | 1 |
| 5 | Glycemic durability of rosiglitazone,metformin,or glyburide monotherapy显示文摘 | Kahn SE Haffner SM Heise MA | 2006 | N Engl J Med2006，355，23： | 1 |
| 6 | The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes显示文摘 | Kahn SE | 2003 | Diabetologia2003，46，1： | 1 |
| 7 | Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy 显示文摘 | Kahn SE Haffner SM Heise MA | 2006 | N Engl J Med2006，355，23： | 1 |
| 8 | Glycemic durabihty of rosiglitazone, mefformin, or glyburide monotherapy 显示文摘 | Kahn SE Haffner SM Heise MA | 2006 | N Engl J Med2006，355，23： | 1 |
| 9 | Mechanisms linking obesity to insulin resistance and type 2 diabetes显示文摘 | Kahn SE Hull RL Utzschneider KM | 2006 | Nature2006，444，7121： | 1 |
| 10 | Review: The role of insulinresistance in nonalcoholic fatty liver disease显示文摘 | Utzschneider KM? Kahn SE | 2006 | J Clin En-docrinol Metab2006，91，12： | 1 |
| 11 | Mechanisms linking obesity to insulin resistance and type 2 diabetes显示文摘 | Kahn SE Hull RL Utzschneider KM | 2006 | Nature2006，444，7121： | 1 |
| 12 | Glycemic durability of rosiglitazone, mefformin, or glyburide monotherapy显示文摘 | Kahn SE Haffner SM Heise MA | 2006 | N Engl J Med2006，355，： | 1 |
| 13 | Reduced anaylin release is a characteristis of impaired glucose tolerance and type 2 diabetes in Japancese Americans显示文摘 | Kahn SE Verchere CB Andrikopulos S | 1998 | Diabetes1998，47，4： | 1 |
| 14 | Oophorectomy promotes islet amyloid formation in a transgenic mouse model of type II diabetes显示文摘 | Kahn SE Andrikopoules S Verchere CB | 2000 | Diabetologia2000，43，10： | 1 |
| 15 | Cardiovascular outcome trials in type 2 diabetes and the sulphonylurea controversy: rationale for the active-comparator CAROLINA trial 显示文摘 | Rosenstock J Marx N Kahn SE | 2013 | Diab Vasc Dis Res2013，10，4： | 1 |
| 16 | Regression from pre-diabetes to normal glucose regulation in the Dia-betes Prevention Program 显示文摘 | Perreault L Kahn SE Chritetophi CA | 2009 | Diabetes Care2009，32，9： | 1 |
| 17 | Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM 显示文摘 | Kahn SE Halban PA | 1997 | Diabetes1997，46，11： | 1 |
| 18 | Cardiovascular outcome trials in type 2 diabetes and the sulphonylurea controversy:rationale for the active-comparator CAROLINA trial显示文摘 | Rosenstock J Marx N Kahn SE | 2013 | Diabetes Vascular Dis Res2013，10，： | 1 |
| 19 | Glycenic durability of rosiglitazone, metformin, or glyburide monotherapy 显示文摘 | Kahn SE Haffner SM Heise MA | 2007 | N Engl J Med2007，355，： | 1 |
| 20 | β-cell dysfunction and failure in type 2 diabetes potential mechanisms 显示文摘 | Porte D Kahn SE | 2001 | Diabetes2001，50，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员